Procter & Gamble Forecast, price target & analysts
Procter & Gamble Target price 2025 - Analyst rating & recommendation
Procter & Gamble Classifications & Recommendation:
Procter & Gamble Price Target
| Target Price | $178.00 |
| Price | $159.53 |
| Potential | 11.58% |
| Number of Estimates | 23 |
| 23 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $178.00. This is 11.58% higher than the current stock price. The highest price target is $200.00 25.37% , the lowest is $157.00 1.59% . | |
| A rating was issued by 29 analysts: 17 Analysts recommend Procter & Gamble to buy, 11 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 11.58% . Most analysts recommend the Procter & Gamble stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2028
21 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $84.6b . This is 0.25% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $85.8b 1.73% , the lowest is $83.6b 0.89% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $84.0b | 2.48% |
|---|---|---|
| 2025 | $84.6b | 0.62% |
| 2026 | $87.1b | 3.00% |
| 2027 | $90.5b | 3.87% |
| 2028 | $93.3b | 3.15% |
19 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $23.6b . This is 4.36% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $24.3b 7.53% , the lowest is $23.0b 1.99% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $23.1b | 9.60% |
|---|---|---|
| 2025 | $23.6b | 2.02% |
| 2026 | $24.7b | 5.01% |
| 2027 | $26.2b | 5.92% |
| 2028 | $27.0b | 3.21% |
EBITDA Margin
| 2024 | 27.48% | 6.95% |
|---|---|---|
| 2025 | 27.86% | 1.38% |
| 2026 | 28.40% | 1.94% |
| 2027 | 28.96% | 1.97% |
| 2028 | 28.98% | 0.07% |
11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.7b . This is 6.42% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.4b 11.31% , the lowest is $15.1b 2.55% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $14.1b | 2.03% |
|---|---|---|
| 2025 | $15.7b | 11.01% |
| 2026 | $16.9b | 7.94% |
| 2027 | $18.0b | 6.60% |
| 2028 | $18.5b | 2.68% |
Net Margin
| 2024 | 16.80% | 0.43% |
|---|---|---|
| 2025 | 18.53% | 10.32% |
| 2026 | 19.42% | 4.80% |
| 2027 | 19.93% | 2.63% |
| 2028 | 19.84% | 0.45% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.68 . This is 6.37% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.99 11.31% , the lowest is $6.44 2.55% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $6.02 | 2.03% |
|---|---|---|
| 2025 | $6.68 | 10.96% |
| 2026 | $7.21 | 7.93% |
| 2027 | $7.69 | 6.66% |
| 2028 | $7.90 | 2.73% |
P/E ratio
| Current | 25.42 | 1.70% |
|---|---|---|
| 2025 | 23.87 | 6.10% |
| 2026 | 22.11 | 7.37% |
| 2027 | 20.75 | 6.15% |
| 2028 | 20.20 | 2.65% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 4.73 and an P/S ratio of 4.42 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.74 | 0.00% |
|---|---|---|
| 2025 | 4.73 | 0.30% |
| 2026 | 4.59 | 2.92% |
| 2027 | 4.42 | 3.73% |
| 2028 | 4.28 | 3.05% |
P/S ratio
| Current | 4.44 | 0.19% |
|---|---|---|
| 2025 | 4.42 | 0.25% |
| 2026 | 4.29 | 2.92% |
| 2027 | 4.13 | 3.73% |
| 2028 | 4.01 | 3.05% |
Procter & Gamble...
Current Procter & Gamble Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Apr 22 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 11 2025 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Apr 03 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 27 2025 |
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Feb 24 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jan 23 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jan 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Apr 22 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 11 2025 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Apr 03 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Mar 27 2025 |
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Feb 24 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jan 23 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jan 23 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
